Skip to content
10-K

Annual Report

CANCER CAPITAL CORP.

0001554795-22-000107

← back to feed
Filed
Mar 22, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 22, 2022 6.15M sh
Operating Cash Flow FY 2021 · Dec 31, 2020 −$8.72K
Cash And Equivalents FY 2021 · Dec 31, 2020 $698
Cash And Equivalents FY 2021 · Dec 31, 2019 $218
Current Liabilities FY 2021 · Dec 31, 2020 $333.04K
Total Liabilities FY 2021 · Dec 31, 2020 $333.04K
Current Assets FY 2021 · Dec 31, 2020 $698
Total Assets FY 2021 · Dec 31, 2020 $698
Sga Expense FY 2021 · Dec 31, 2020 $13.52K
Net Income FY 2021 · Dec 31, 2020 −$30.75K
Operating Income FY 2021 · Dec 31, 2020 −$13.52K
Stockholders Equity FY 2021 · Dec 31, 2019 −$301.59K